<DOC>
	<DOCNO>NCT02746783</DOCNO>
	<brief_summary>This study assess effect different dose seasonal flu vaccine 2013-2014 immune response improve investigator understand cellular humoral immune response induce . The scope study determine profile cellular activation antibody production age immune system follow flu immunization . This study enroll 100 male female subject ≥65 year old . These person deem `` risk `` case influenza infection vaccinate accord Swiss Federal Office Public Health . A medical doctor CHUV inform patient present study ask whether would willing participate study . All subject distribute two group accord computer-generated randomization sequence . The randomization do block ensure balance across group . The participant site staff blind due different administration assignment . Group 1 subject receive single dose group 2 subject double dose MUTAGRIP® manufacture Sanofi Pasteur contain A/California/7/2009 ( H1N1 ) ; A/Texas/50/2012 ( H3N2 ) ; B/Massachusetts/2/2012 . Vaccine immunogenicity safety assess 1 , 2 , 4 24 week vaccination . Study duration per volunteer 6 month vaccination .</brief_summary>
	<brief_title>Immunogenicity ( Humoral Cellular Immune Responses ) Safety 2013-2014 Seasonal Flu Vaccine Elderly</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Age ≥65 year old . Able give inform consent . Necessity receive influenza seasonal vaccination 20132014 . Availability duration study willingness attend schedule visit . Hemoglobin value ≥100 g/l , Leukocytes ≥3.5 G/L , Platelets count ≥100 G/l time screening , determine within 8 week screen course regular medical examination validate medical doctor . Contraindication seasonal flu vaccination . Use investigational nonregistered drug vaccine within 30 day precede first dose study vaccine , plan use study period safety followup . Immunodeficiency chronic administration ( define 14 consecutive day ) immunosuppressive immunemodifying drug within six month prior first vaccine dose . ( For corticosteroid , mean prednisone , equivalent , ≥0.5 mg/kg/day . Inhaled topical steroid allow ) . Hypersensitivity active substance , excipients , egg , chicken protein , neomycin , formaldehyde octoxinol 9 . Acute disease time enrollment [ Acute disease define presence moderate severe illness without fever . All vaccine administer person minor illness diarrhea , mild upper respiratory infection without lowgrade febrile illness , i.e. , temperature &lt; 38°C ] . An unstable chronic condition ( unstable chronic renal failure , unstable diabetes , unstable chronic cardiac condition , uncontrolled asthma , etc. ) . Receipt bloodderived product ( immunoglobulin ; plasma ) within 120 day prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>